Blood Biomarkers Predict TBI Disability, Mortality

Measuring GFAP and UCH-L1 in blood on the day of injury may give a more accurate assessment of a patient's prognosis following traumatic brain injury, new research suggests.

Related Keywords

Ann Arbor ,Michigan ,United States ,Frederick Korley ,Drug Administration ,International Mission For Prognosis ,Abbott Labs ,University Of Michigan ,Medscape Medical News ,Glasgow Coma Scale ,International Mission ,Clinical Trials ,Medscape Medical ,Traumatic Brain Injury ,Bi Traumatic Brain Injury ,Biomarker ,Iological Marker ,Concussion ,Mild Traumatic Brain Injury ,Mild Tbi ,Tbi Mild Traumatic Brain Injury ,Injury ,Wound Management ,Motor Vehicle Accident ,Disability ,Prognosis ,Clinical Research ,Linical Studies ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,